For now, her focus is on making the most of its existing portfolio, notably Keytruda – the world’s top-selling cancer drug – ...

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...

WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...

MSD has invested around €2.2bn since first setting up a presence in Ireland 50 years ago. It currently employs around 500 people in Carlow and 1,800 in total across its manufacturing, R&D, support ...

In 2017, MSD made the decision to open a ... this year it had decided to build a $360 million manufacturing facility in the Republic of Ireland instead of the UK, blaming the tax burden imposed ...

What a start to 2025. MSD has agreed to acquire the Wuxi Vaccines manufacturing facility located in Dundalk, Co Louth. Together with the acquisition, the company is looking ahead to significant ...

MSD Ireland, one of Ireland’s leading healthcare companies ... The new expansion is scheduled to commence manufacturing operations in 2022 and will employ an additional 170 staff and 100 contractor ...

GE HealthCare invests $138 million in Cork, Ireland manufacturing facility to address increasing contrast media demand ...

GE HealthCare announced a $138 million investment to expand its contrast media fill/finish manufacturing site in Cork, ...